SCHEMBL6507865

SCHEMBL6507865

CC(C)C[C@H](Nc1nc(Nc2cccc(F)c2)cc(Sc2ccc3ccccc3n2)n1)C(=O)NCC1CCCO1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.41
HPGD P15428 4/20 0.39
CYP2C9 P11712 3/20 0.39
CYP2C19 P33261 3/20 0.39
GAA P10253 2/20 0.39
CYP1A2 P05177 2/20 0.39
KMT2A Q03164 4/20 0.39
RXFP1 Q9HBX9 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
RAB9A P51151 1/20 0.38
ALDH1A1 P00352 6/20 0.37
KDM4E B2RXH2 4/20 0.37
HSD17B10 Q99714 3/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 2/20 0.37
CASP1 P29466 2/20 0.37
NPSR1 Q6W5P4 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2D6 P10635 2/20 0.36
POLB P06746 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6513920 0.85 CTSK (0.40) HTTHPGDCYP2C9CYP2C19GAA
SCHEMBL6510400 0.84 HPGD (0.44) HPGDCYP2C9CYP2C19GAACYP1A2
SCHEMBL6507866 0.78 HTT (0.34) HTTHPGDCYP2C9CYP2C19GAA
SCHEMBL6512023 0.73 ALDH1A1 (0.40) HTTHPGDGAAKMT2ASMN1; SMN2
SCHEMBL6532622 0.71 KCNH3 (0.51) HTTHPGDCYP2C9CYP2C19GAA
SCHEMBL6532631 0.71 KCNH3 (0.51) HTTHPGDCYP2C9CYP2C19GAA
SCHEMBL6531846 0.70 HPGD (0.44) HTTHPGDGAASMN1; SMN2RAB9A
SCHEMBL6513831 0.69 CTSK (0.44) CYP2C9CYP2C19CYP1A2ALDH1A1CYP2D6
SCHEMBL6506223 0.69 CTSK (0.42) CYP2C9CYP2C19GAACYP1A2KMT2A
SCHEMBL6509302 0.69 PDPK1 (0.41) HTTHPGDCYP2C9CYP2C19GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO claimed
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed